Navigation Links
Orexigen Resubmits Contrave New Drug Application
Date:12/11/2013

most frequent adverse events in patients on Contrave were nausea, constipation, headache, vomiting, dizziness, insomnia, dry mouth, and diarrhea. These were mostly mild to moderate in severity.

Orexigen has licensed North American Contrave rights to Takeda Pharmaceuticals. Orexigen owns Contrave rights in Europe and throughout the rest of the world outside of North America and will seek a partner to commercialize Contrave in those territories. In October 2013, Orexigen submitted a Marketing Authorization Application (MAA) for Contrave to the European Medicines Agency (EMA).

About Orexigen TherapeuticsOrexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave, which the Company is evaluating in the Light Study, a cardiovascular outcomes trial being conducted under a Special Protocol Assessment (SPA) with the FDA. Based on successful results of the Light Study, the Company resubmitted the Contrave NDA to the FDA. The Company's other product candidate, Empatic, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com.

Forward‐Looking Statements
Orexigen cautions you that statements included in this press release that are not a description of historical facts are forward‐looking statements. Words such as "believes," "anticipates," "plans," "expects," "indicates," "will," "should," "intends," "potential," "suggests," "assuming," "designed" and similar expressions are intended to identify forward‐looking statements. These statements are based on the Company's current beliefs and expectations. These forward‐looking statements include statements regarding: the timing of potential approval of the NDA for Contrave in the U.S. and the MAA for Contrave by the European Medicines Agency (EMA); the benefit
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes
2. Orexigen Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
3. Orexigen Announces Successful Interim Analysis of Contrave Light Study
4. Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast
5. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
6. Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta
7. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
8. A Balanced Risk-Benefit Profile Will Propel Orexigen/Takedas Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
9. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
10. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
11. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)...  Kindred Hospital Houston Northwest, with Wound Care ... its new outpatient wound healing center.  The wound ... chronic, hard to heal wounds. Chronic wounds include ... lower leg wounds related to blood flow issues, ... injury wounds which are complex and demonstrate delayed ...
(Date:7/11/2014)... 2014  Veran Medical Technologies, a U.S. ... positive, cost-effective final results for the initial ... SPiNPerc endobronchial percutaneous biopsy study results support ... biopsy when a traditional bronchoscopic method is ... positive financial outcomes when more can be ...
(Date:7/10/2014)... July 10, 2014  The U.S. Department of Health ... to University Hospitals (UH) Case Medical Center Seidman Cancer ... model aimed at improving care for patients with complex ... project will test a unique model developed at UH ... disease, significant comorbidities, or demonstrated need for high health ...
Breaking Medicine Technology:Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Veran Medical Publishes Lung Cancer Patient Management Study 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4
... 11, 2011 Reportlinker.com announces that ... available in its catalogue: ... New pricing rules set to negatively ... internationally http://www.reportlinker.com/p0360217/Germany-Pharmaceutical-Market-Overview-–-New-pricing-rules-set-to-negatively-impact-drug-sales-both-domestically-and-internationally.html ...
... 11, 2011 Reportlinker.com announces that a new ... The Endoscopy Device Market Outlook ... Introduction This endoscopy device market ... global market, covering endoscopic accessories, instruments, endoscopes, and ...
Cached Medicine Technology:Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally 2Reportlinker Adds The Endoscopy Device Market Outlook to 2015 2
(Date:7/12/2014)... (PRWEB) July 12, 2014 Wright & Schulte ... clients in Just For Men Lawsuits (case #59776/2014), announces ... consumers of reports that allege the popular hair dye, Just ... burns to their face, neck and other areas. In addition ... For Men chemical burns , the advertisements being run by ...
(Date:7/12/2014)... 12, 2014 Maxim Peptide, a website ... are used solely in scientific experiments, is currently celebrating ... in business, Maxim Peptide, which was created by the ... new and updated website that now features a special ... been updated with fascinating articles about peptide research, including ...
(Date:7/11/2014)... Recently, MagicQuinceaneraDresses.com, the popular online supplier of special occasion ... Quinceanera dresses . The company’s new items are specially ... paying a large amount of money. They are all ... The company’s online shop has become a one stop ... In addition to exquisite Quinceanera dresses, it also offers ...
(Date:7/11/2014)... According to new report "C4ISR Market (2014 ... register a CAGR of 2.28% to reach $93.04 ... tables and 76 figures spread through 185 pages ... , Early buyers will receive 10% customization ... report provides market analysis of the global C4ISR ...
(Date:7/11/2014)... PA (PRWEB) July 11, 2014 Butler Mobility ... of Inclined Platform Lifts . Previously the two ... offering five new beautiful earth tone colors as standard colors ... blend well in the home but will enhance the beauty ... choice for any home color scheme or individual décor. , ...
Breaking Medicine News(10 mins):Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 4Health News:Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 3Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2
... -- The risk of fractures after weight-loss surgery may be ... Prior research has shown that people who undergo surgery to ... for bone fractures. One study, for example, showed a 1.8-fold ... But further analysis showed the risk was actually closer to ...
... thought to accelerate tumor growth in thyroid cancer patients ... for novel cancer therapies, a Mayo Clinic study has ... Clinic researcher Honey Reddi, Ph.D., at the Endocrine Society ... widespread implications in cancer research and endocrinology . ...
... womb can program the potential for adverse health effects in ... on whether the mother or father transmits them, a new ... The Endocrine Society,s 93rd Annual Meeting in Boston. "This ... the womb to excessive levels of stress hormones, known as ...
... 2011 - Additional radiation treatment improves disease free survival ... early breast cancer who have had breast conserving surgery ... results will be presented Monday, June 6 at the ... "These results are potentially practice-changing," said Dr. ...
... -- Medical students who are physically fit are more likely ... new study. Researchers found that medical students who ... physical activity guidelines often felt strongly that being active themselves ... treating. In analyzing certain markers of physical health -- ...
... News) -- College athletes who suffer a concussion may ... concussion is a head injury that can cause headache, ... hearing, as well as difficulty following instructions. "This ... in student-athletes," study author Robert Gardner, a student ...
Cached Medicine News:Health News:Weight-Loss Surgery Linked to Rise in Fracture Risk 2Health News:Fighting cancer with cancer: Mayo Clinic finds promising use for thyroid cancer gene 2Health News:Fetal programming of disease risk to next generation depends on parental gender 2Health News:Breast cancer surgery patients benefit from adding radiation therapy 2Health News:Fit Doctors More Likely to Prescribe Exercise: Study 2Health News:Concussions Tied to Verbal Memory Loss in Young Athletes 2
Bayonet Kerrison Rongeur, ceramic ejector, 9.5 length 40 Fwd, 6.5 working length 165 mm....
Hardy Micro Dissector, bayonet. Working distance 4 1/4" (120 mm). Angled up, tip width: 2 mm....
Papavero-caspar specula for trans-sphenoidal hypophysectomy....
Fahlbusch hypophysectomie instrument, spoon, bayonet-shaped, malleable....
Medicine Products: